ATRION/ATRI

$358.87

-2.47%
-
1D1W1MYTD1YMAX

About ATRION

Atrion Corporation (Atrion) is engaged in the development and manufacture of products for medical applications. The Company's medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. It has developed a variety of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous, catheter and other applications in fields, such as anesthesia and oncology. Atrion's cardiovascular product, Myocardial Protection System (MPS3), is a technology used in open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. Atrion also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Its medical and non-medical products are manufactured at facilities in Florida, Alabama and Texas.

Ticker

ATRI

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Emile Battat

Employees

722

Headquarters

Allen, United States

ATRION Metrics

BasicAdvanced
$647.6M
Market cap
30.49
P/E ratio
$12.07
EPS
0.58
Beta
$8.65
Dividend rate
2.39%
Dividend yield

ATRION Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
6.92% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$41.9M
-4.34%
Net income
$2.9M
-55.38%
Profit margin
6.92%
-53.37%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell ATRION stock

Buy or sell ATRION stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing